Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

4.11
Delayed Data
As of Jul 21
 -0.21 / -4.86%
Today’s Change
3.15
Today|||52-Week Range
9.49
-0.48%
Year-to-Date

Today’s Trading

Previous close4.32
Today’s open4.38
Day’s range4.09 - 4.38
Volume1,681,353
Average volume (3 months)1,499,935
Market cap$561.9M
Dividend yield--
Data as of 3:59pm ET, 07/21/2017

Growth & Valuation

Earnings growth (last year)-1,025.00%
Earnings growth (this year)-52.00%
Earnings growth (next 5 years)+5.23%
Revenue growth (last year)-77.31%
P/E ratioNM
Price/Sales37.63
Price/Book1.41

Competitors

 Today’s
change
Today’s
% change
DOVADova Pharmaceuticals...-0.02-0.09%
SCLNSciClone Pharmaceuti...+0.10+0.92%
OTICOtonomy Inc+0.15+0.80%
ITCIIntra-Cellular Thera...-0.29-2.25%
Data as of 4:00pm ET, 07/21/2017

Financials

Next reporting dateAugust 9, 2017
EPS forecast (this quarter)-$0.16
Annual revenue (last year)$15.0M
Annual profit (last year)-$61.7M
Net profit margin-411.37%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Milind S. Deshpande
CFO, Principal Accounting Officer &
Executive VP
Mary Kay Fenton
Corporate headquarters
New Haven, Connecticut

Forecasts